170 related articles for article (PubMed ID: 9159347)
41. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma.
Jablkowski M; Bocian A; Bialkowska J; Bartkowiak J
J Exp Clin Cancer Res; 2005 Mar; 24(1):117-25. PubMed ID: 15943041
[TBL] [Abstract][Full Text] [Related]
42. Results of p53 analysis in pediatric malignancies in Poland.
Fiszer-Maliszewska Ł; Czernik J; Sawicz-Birkowska K; Kazanowska B; Wojciechowska B
Med Pediatr Oncol; 2003 May; 40(5):316-21. PubMed ID: 12652620
[TBL] [Abstract][Full Text] [Related]
43. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas.
Nasir L; Rutteman GR; Reid SW; Schulze C; Argyle DJ
Cancer Lett; 2001 Dec; 174(1):83-9. PubMed ID: 11675155
[TBL] [Abstract][Full Text] [Related]
44. p53 mutations and MDM-2 amplification in renal cell cancers.
Imai Y; Strohmeyer TG; Fleischhacker M; Slamon DJ; Koeffler HP
Mod Pathol; 1994 Sep; 7(7):766-70. PubMed ID: 7824511
[TBL] [Abstract][Full Text] [Related]
45. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
[TBL] [Abstract][Full Text] [Related]
46. Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors.
Würl P; Taubert H; Bache M; Kroll J; Meye A; Berger D; Siermann A; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Int J Cancer; 1996 Aug; 69(4):317-23. PubMed ID: 8797875
[TBL] [Abstract][Full Text] [Related]
47. Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.
Liegl-Atzwanger B; Heitzer E; Flicker K; Müller S; Ulz P; Saglam O; Tavassoli F; Devouassoux-Shisheboran M; Geigl J; Moinfar F
Mod Pathol; 2016 Oct; 29(10):1262-77. PubMed ID: 27363490
[TBL] [Abstract][Full Text] [Related]
48. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
[TBL] [Abstract][Full Text] [Related]
49. Alterations in the K-ras and p53 genes in rat lung tumors.
Belinsky SA; Swafford DS; Finch GL; Mitchell CE; Kelly G; Hahn FF; Anderson MW; Nikula KJ
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):901-6. PubMed ID: 9255578
[TBL] [Abstract][Full Text] [Related]
50. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
51. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
[TBL] [Abstract][Full Text] [Related]
52. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
[TBL] [Abstract][Full Text] [Related]
53. P53 mutations in Ewing's sarcoma.
Park YK; Chi SG; Kim YW; Park HR; Unni KK
Oncol Rep; 2001; 8(3):533-7. PubMed ID: 11295075
[TBL] [Abstract][Full Text] [Related]
54. Chromosome aberrations and expression of ras and myc oncogenes in leiomyomas and a leiomyosarcoma of the uterus.
Fotiou SK; Tserkezoglou AJ; Mahera H; Konstandinidou AE; Agnantis NJ; Pandis N; Bardi G
Eur J Gynaecol Oncol; 1992; 13(4):340-5. PubMed ID: 1516585
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.
Zhai YL; Nikaido T; Toki T; Shiozawa A; Orii A; Fujii S
Br J Cancer; 1999 Jul; 80(10):1658-64. PubMed ID: 10408415
[TBL] [Abstract][Full Text] [Related]
56. Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.
Lee JH; Ryu TY; Cho CH; Kim DK
Pathol Oncol Res; 2011 Jun; 17(2):201-5. PubMed ID: 20853077
[TBL] [Abstract][Full Text] [Related]
57. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
[TBL] [Abstract][Full Text] [Related]
58. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert AD; D'Antonio A; Losito S; Normanno N; Salomon DS
J Pathol; 2007 Jan; 211(1):36-44. PubMed ID: 17072826
[TBL] [Abstract][Full Text] [Related]
59. Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia.
Gaidano G; Pastore C; Santini V; Nomdedeu J; Gamberi B; Capello D; Vischia F; Resegotti L; Mazza U; Ferrini PR; Lo Coco F; Saglio G
Genes Chromosomes Cancer; 1997 Aug; 19(4):250-5. PubMed ID: 9258660
[TBL] [Abstract][Full Text] [Related]
60. Alterations of the Rb gene and its association with Ki-ras activation and p53 inactivation in endometrial adenocarcinoma.
Enomoto T; Fujita M; Inoue M; Nakazawa-Miyamoto A; Tanizawa O; Nomura T
Mol Carcinog; 1993; 8(3):132-7. PubMed ID: 8105795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]